NCT07685561

Brief Summary

The purpose of this study is to determine whether the addition of a home-based high-intensity knee extension stretching device (Ermi Knee Extensionater) to standard postoperative physical therapy improves recovery of full knee extension following ACL reconstruction compared with standard physical therapy alone.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P50-P75 for phase_1

Timeline
68mo left

Started Aug 2026

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
26 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2032

Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

5.6 years

First QC Date

June 30, 2026

Last Update Submit

June 30, 2026

Conditions

Keywords

ACLKneeknee reconstructionErmi Knee Extensionator

Outcome Measures

Primary Outcomes (1)

  • Changes in Knee Range of Motion

    A goniometer will be used to measure the post operative knee's range of motion an angle or to rotate an object to a precise angular position.

    Baseline, 2 weeks, 6 weeks, and 3 months

Study Arms (2)

Participants Receiving Standard of Care

ACTIVE COMPARATOR

Patients will receive standard physical therapy alone: postoperative rehabilitation as per the treating clinician's standard ACL protocol (this may include use of the Knee Extensionater in a clinical setting).

Behavioral: Standard Physical Therapy

Patient Receiving Ermi Knee Extensionator + Standard of Care

EXPERIMENTAL

Patients will receive the Ermi Knee Extensionater plus standard physical therapy: Standard rehabilitation protocol plus daily home use of the Knee Extensionater for terminal extension stretching.

Behavioral: Standard Physical TherapyDevice: Ermi Knee Extensionater

Interventions

Routine standard physical therapy for post op knee reconstructive surgery. May include use of knee Extensionator in a clinic setting.

Participants Receiving Standard of CarePatient Receiving Ermi Knee Extensionator + Standard of Care

Standard rehabilitation protocol plus daily home use of the Knee Extensionater for terminal extension stretching. The Ermi device will be distributed to all participants in Arm 2 preoperatively. Stretching protocols will be provided at this time. Following surgery, participants must complete daily home stretching sessions (60 total minutes of end-range stretching per day) starting at postoperative day one. Each stretching session is broken down into 10 minutes of stretching, followed by 10 minutes of rest. This is repeated throughout the day until a total of 60 minutes of stretching is completed. There should be at least one hour between sessions. Stretching sessions will continue until 3 months postop.

Patient Receiving Ermi Knee Extensionator + Standard of Care

Eligibility Criteria

Age14 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 14-65 yo
  • Primary ACLR (BTB auto ONLY)
  • Prior ACL tear treated non-op

You may not qualify if:

  • Revision ACL surgery
  • Major concomitant ligament reconstruction
  • Neurologic lower-extremity disorder
  • Inability to complete rehab
  • Cognitive impairment preventing consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35243, United States

Location

Study Officials

  • Amit Momaya, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 30, 2026

First Posted

July 6, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

March 1, 2032

Study Completion (Estimated)

March 1, 2032

Last Updated

July 6, 2026

Record last verified: 2026-06

Locations